Koers Vycor Medical, Inc. Other OTC
Aandelen
VYCO
US92921M2035
Medische apparatuur, benodigdheden & distributie
Omzet 2022 | 1,22 mln. 1,13 mln. | Omzet 2023 | 1,46 mln. 1,35 mln. | Marktkapitalisatie | 2,52 mln. 2,32 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 3,18 x |
Nettoschuld 2022 | 957K 883K | Nettoschuld 2023 | 1,05 mln. 972K | EV/omzet 2023 | 2,45 x |
K/w-verhouding 2022 |
-3,91
x | K/w-verhouding 2023 |
-6,39
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 37,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Peter Zachariou
CEO | Chief Executive Officer | 62 | 14-05-10 |
President | 57 | 01-01-10 | |
Chairman | 65 | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Zachariou
CEO | Chief Executive Officer | 62 | 14-05-10 |
Chairman | 65 | 01-01-10 | |
President | 57 | 01-01-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,51% | 179 mld. | |
+3,91% | 113 mld. | |
-3,41% | 67,88 mld. | |
+5,23% | 52,03 mld. | |
+5,51% | 43,3 mld. | |
+4,03% | 41,79 mld. | |
+24,79% | 32,49 mld. | |
+14,00% | 25,65 mld. | |
-4,75% | 24,55 mld. |